Although market SP is manipulated, IER will weigh in Sleepcheck FDA, Cough sound patent, and the data confirmation result. I will be surprised if the valuations are same as it was. However nobody, including Pfizer, want to waste a few more weeks to amend the already ASIC submitted scheme (Manipulation has a cost, and quarterly figure is coming). The exception is they have to based on IER revised value.
- Forums
- ASX - By Stock
- RAP
- Ann: ResApp receives FDA 510(k) clearance for SleepCheckRx
Ann: ResApp receives FDA 510(k) clearance for SleepCheckRx, page-42
-
- There are more pages in this discussion • 85 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add RAP (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
LU7
LITHIUM UNIVERSE LIMITED
Alex Hanly, CEO
Alex Hanly
CEO
SPONSORED BY The Market Online